4//SEC Filing
Mulligan Seamus 4
Accession 0001765581-25-000076
CIK 0001232524other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 5:32 PM ET
Size
6.0 KB
Accession
0001765581-25-000076
Insider Transaction Report
Form 4
Mulligan Seamus
Director
Transactions
- Award
Ordinary Shares
2025-08-07+3,507→ 1,179,613 total
Holdings
- 101,621(indirect: By Nerano Pharma Lim)
Ordinary Shares
Footnotes (2)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026.
- [F2]Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001536639
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 5:32 PM ET
- Size
- 6.0 KB